The dynamics of glycosylation in trophoblast cells: development, function, and pregnancy-related disorders

Trophoblast cells are essential for embryo implantation and placental development, with their functional versatility critically regulated by dynamic glycosylation modifications. These post-translational modifications create a spatiotemporally-defined molecular code that directs trophoblast behavior throughout pregnancy, though its comprehensive role in both physiological and pathological contexts remains to be fully elucidated. Glycosylation orchestrates key trophoblast functions in a stage-specific manner. During early pregnancy, specific glycan patterns mediate blastocyst adhesion and trophoblast invasion via modifications to integrins, cadherins, and selectins. As placental development progresses, spatially restricted glycosyltransferases guide cytotrophoblast differentiation into syncytiotrophoblasts and extravillous trophoblasts, modulating critical signaling pathways including Wnt, Notch, and FGF. Glycosylation further regulates maternal–fetal immune tolerance through cytokine receptor modifications and sialylated glycan interactions with inhibitory immune receptors. Disruptions to this spatiotemporal glycan landscape—manifested as aberrant sialylation, fucosylation, and N-glycan branching—are mechanistically linked to pregnancy disorders including preeclampsia, gestational diabetes, recurrent pregnancy loss, and choriocarcinoma. Emerging technologies such as single-cell glycomics and trophoblast organoids are now decoding this intricate regulatory system with unprecedented resolution, bridging molecular mechanisms with clinical phenotypes. Glycosylation constitutes a master regulatory code that coordinates trophoblast development and function across gestation. The spatiotemporal specificity of glycosylation patterns ensures proper placentation and maternal–fetal interface maintenance, while its dysregulation contributes significantly to pregnancy pathologies. Understanding this dynamic system opens new avenues for biomarker discovery and therapeutic interventions, with emerging glycomic technologies poised to translate these findings into clinical applications for managing complicated pregnancies.滋养层细胞（Trophoblast cells）是胚胎着床与胎盘发育的关键细胞群体，其功能多样性受动态糖基化修饰（glycosylation modifications）的精密调控。这类翻译后修饰（post-translational modifications）构建了一套时空特异性的分子编码，在整个妊娠周期中指导滋养层细胞的行为模式，但该编码在生理与病理场景中的完整功能仍有待全面阐明。 糖基化以阶段特异性方式调控滋养层细胞的核心功能。妊娠早期，特定的聚糖模式通过修饰整合素（integrins）、钙粘蛋白（cadherins）与选择素（selectins），介导囊胚黏附与滋养层细胞侵袭。随着胎盘发育进程推进，空间限制性表达的糖基转移酶（glycosyltransferases）引导细胞滋养层细胞（cytotrophoblast）分化为合体滋养层细胞（syncytiotrophoblasts）与绒毛外滋养层细胞（extravillous trophoblasts），并调控包括Wnt、Notch及FGF在内的关键信号通路。糖基化还可通过细胞因子受体修饰以及唾液酸化聚糖与抑制性免疫受体的相互作用，调控母胎免疫耐受。该时空特异性聚糖图谱的紊乱——表现为异常的唾液酸化（sialylation）、岩藻糖基化（fucosylation）与N-聚糖分支（N-glycan branching）——在机制上与子痫前期（preeclampsia）、妊娠期糖尿病（gestational diabetes）、复发性流产（recurrent pregnancy loss）及绒毛膜癌（choriocarcinoma）等妊娠疾病密切相关。 新兴技术如单细胞糖组学（single-cell glycomics）与滋养层类器官（trophoblast organoids）正以前所未有的分辨率解析这一复杂的调控网络，将分子机制与临床表型建立起直接关联。 糖基化构成一套核心调控编码，在整个妊娠周期中协调滋养层细胞的发育与功能。聚糖模式的时空特异性保障了正常胎盘形成与母胎界面稳态维持，而其失调则显著参与妊娠病理过程。阐明这一动态调控系统为生物标志物（biomarker）发现与治疗干预（therapeutic interventions）开辟了全新途径，新兴的糖组学技术有望将这些研究成果转化为管理复杂妊娠的临床应用方案。